Css LLC Takeda Pharmaceutical CO LTD Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $115,425 - $142,275	7,500 Added 16.0%	54,384 $990,000
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $62,432 - $70,062	3,651 Added 8.44%	46,884 $836,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $186,781 - $249,639	-12,802 Reduced 22.85%	43,233 $775,000
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $837,524 - $1.31 Million	-64,326 Reduced 53.44%	56,035 $851,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $361,096 - $445,595	-21,392 Reduced 15.09%	120,361 $2.38 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $142,539 - $158,779	8,826 Added 6.64%	141,753 $2.44 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $59,538 - $73,579	3,591 Added 2.78%	132,927 $2.35 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $2.16 Million - $2.78 Million	129,336 New	129,336 $2.63 Million

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.7B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.